Unveiling Cencora (COR) Q4 Outlook: Wall Street Estimates for Key MetricsZacks Investment Research • 8h
Cencora (COR) Reports Next Week: Wall Street Expects Earnings GrowthZacks Investment Research • Wednesday
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Surgery Partners, Inc. (Nasdaq – SGRY), Range Resources Corporation (NYSE – RRC), American Oncology Network, Inc. (OTCQX – AONC), Utz Brands, Inc. (NYSE – UTZ)GlobeNewsWire • Monday
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Passage Bio, Inc. (Nasdaq – PASG), American Oncology Network, Inc. (OTCQX – AONC), Utz Brands, Inc. (NYSE – UTZ), Finward Bancorp (Nasdaq – FNWD)GlobeNewsWire • 10/21/26
Cencora to Acquire American Oncology Network to Strengthen Support of Community OncologyBusiness Wire • 10/21/26
Cencora Announces Date and Time for Fourth Quarter Fiscal 2026 Earnings ReleaseBusiness Wire • 10/02/26
Cencora Highlights Specialty Growth, MSO Expansion and Walgreens Ties at ConferenceMarketBeat • 09/21/26
Cencora, Inc. (COR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/15/26
Cencora, Inc. (COR) Presents at Wells Fargo 21st Annual Healthcare Conference TranscriptSeeking Alpha • 09/08/26
Here's Why You Should Retain Cencora Stock in Your Portfolio for NowZacks Investment Research • 09/04/26
Cencora (COR) Up 3.8% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 09/04/26
Cencora Launches Cell and Gene Therapy Enablement for Health SystemsZacks Investment Research • 09/04/26
Cencora Raises 2026 EPS Outlook as Specialty Businesses StrengthenZacks Investment Research • 09/03/26